Peregrine Pharmaceuticals Inc. (MM) Stock Price - PPHM

Best deals to access real time data!
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
Ultimate Trader (Monthly)
Monthly Subscription
for only
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type ISIN Company Description
Peregrine Pharmaceuticals Inc. (MM) PPHM NASDAQ Common Stock US7136613046
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded DELAYED
  +0.00 +0.00% 0.6764 - - - 0.6764 02:05:03
Bid Price Ask Price Spread Spread % News
0.665 0.689 0.024 3.48% - -
Last Trade Time Type Quantity Stock Price Currency
- - - USD

Peregrine Pharmaceuticals Inc. (MM) Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 201.37M 297.71M $ -55.65M -0.28 0.00 213.9M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
4.25M $ 0.00 0.00% - 22.00%

more financials information »

Peregrine Pharmaceuticals Inc. (MM) News

Date Time Source News Article
3/23/201707:05GlobeNewswire Inc.Peregrine Pharmaceuticals Announces Five Abstracts Accepted..
3/13/201716:48Edgar (US Regulatory)Quarterly Report (10-q)
3/13/201716:35Edgar (US Regulatory)Current Report Filing (8-k)
3/13/201716:05GlobeNewswire Inc.Peregrine Pharmaceuticals Reports Financial Results for the..
3/10/201716:50Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)
3/09/201716:27Edgar (US Regulatory)Current Report Filing (8-k)
3/09/201716:05GlobeNewswire Inc.Peregrine Pharmaceuticals Declares Quarterly Dividend on Its..

Historical PPHM Price Data

Period † Open High Low VWAP Min Vol Max Vol Avg. Daily Vol [m] Change %
1 Week0.680.730.640.00002M5M3M-0.0036-0.53%
1 Month0.48330.7740.48250.00001M15M5M0.193139.95%
3 Months0.31170.7740.2820.0000776k27M4M0.3647117.00%
6 Months0.410.7740.2820.0000305k27M3M0.266464.98%
1 Year0.4020.7740.2820.0000302k27M2M0.274468.26%
3 Years1.942.090.2820.0000027M1M-1.2636-65.13%
5 Years0.505.500.2820.0000068M2M0.176435.28%

Peregrine Pharmaceuticals Inc. (MM) Description

Peregrine Pharmaceuticals, Inc. is a biopharmaceutical company developing first-in-class monoclonal antibodies for the treatment and diagnosis of cancer.
Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:33 V: D:20170324 08:09:34